Back
Health Catalyst, Inc. 10K Form
Sell
32
HCAT
Health Catalyst, Inc.
Last Price:
$2.70
Seasonality Move:
-18.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HCAT News And Ratings
See the #1 stock for the next 7 days that we like better than HCAT
HCAT Financial Statistics
Sales & Book Value
| Annual Sales: | $306.6M |
|---|---|
| Cash Flow: | $-5.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.70 |
| Price / Book: | 0.57 |
Profitability
| EPS (TTM): | -1.58220 |
|---|---|
| Net Income (TTM): | $-107.6M |
| Gross Margin: | $100.4M |
| Return on Equity: | -30.29% |
| Return on Assets: | -14.29% |
Health Catalyst, Inc. Earnings Forecast
Key Health Catalyst, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for HCAT is 32.74%.
-
The Selling, General & Administrative Expenses for HCAT have been equal to 36.27% of Gross Profit Margin.
-
The Research & Development expenses have been 18.53% of Revenue.
-
The Net Earning history of HCAT is -22.67% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 4 years.
Health Catalyst, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | HCAT |
| CUSIP: | 42225T |
| Website: | healthcatalyst.com |
Debt
| Debt-to-Equity Ratio: | 0.52 |
|---|---|
| Current Ratio: | 1.86 |
| Quick Ratio: | 1.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 7.3 |
HCAT Technical Analysis vs Fundamental Analysis
Sell
32
Health Catalyst, Inc. (HCAT)
is a Sell
Is Health Catalyst, Inc. a Buy or a Sell?
-
Health Catalyst, Inc. stock is rated a SellThe current Health Catalyst, Inc. [HCAT] share price is $2.69. The Score for HCAT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.